Linked Data API

Show Search Form

Search Results

1156545
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Drugs and Medical Equipment more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what preventive measures they have put in place to protect the NHS from running short of essential medicines and medical supplies in preparation for a possible no-deal Brexit on 31 October or any other date; and what estimate they have made of the costs incurred from such measures. more like this
tabling member printed
Baroness Altmann more like this
uin HL425 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T17:12:17.847Zmore like thismore than 2019-11-05T17:12:17.847Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4533
label Biography information for Baroness Altmann more like this
1156546
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Nurses: Pensions more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how many NHS practice nurses in England, after working in NHS GP practices across the country, have been excluded from the NHS pension arrangements available to other NHS staff; what estimate they have made of the pension such nurses would have accrued, on average, had they been able to accrue pensions in the same way as nurses working in other parts of the NHS. more like this
tabling member printed
Baroness Altmann more like this
uin HL426 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T17:12:28.55Zmore like thismore than 2019-11-05T17:12:28.55Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4533
label Biography information for Baroness Altmann more like this
1156547
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Doctors: Pensions more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what is their estimate of how many NHS senior medical staff have been asked to pay extra tax as a result of their pension contributions exceeding the Tapered Annual Allowance in the (1) 2016–17, (2) 2017–18, and (3) 2018–19 tax years; and what was the average amount of tax that such staff were asked to pay in each of those years. more like this
tabling member printed
Baroness Altmann more like this
uin HL427 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T17:14:43.543Zmore like thismore than 2019-11-05T17:14:43.543Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4533
label Biography information for Baroness Altmann more like this
1156574
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liothyronine: West Midlands more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what action can be taken by thyroid patents who in raising concerns about the Birmingham and Solihull Clinical Commissioning Group's (CCG) refusal to allow the prescription of liothyronine, were told by that CCG to raise the issue with NHS England only to be told by NHS England to raise the matter with that CCG. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL454 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-04more like thismore than 2019-11-04
answer text <p>Clinical commissioning groups (CCG) are the responsible commissioner for this prescription of liothyronine. NHS England and NHS Improvement has set out its position and it is for CCGs to have regard to that guidance. If a CCG has a commissioning policy that differs from the guidance, then it is for the CCG to explain to patients why this is the case and the basis on which their decision was made. Therefore, patients should raise their concerns with the CCG. NHS England and NHS Improvement’s guidance does not remove the discretion of individual prescribers who remain responsible for clinical decisions relating to their patient’s care.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-04T14:52:26.587Zmore like thismore than 2019-11-04T14:52:26.587Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156575
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liothyronine more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what action they are taking to ensure that the updated prescribing guidance for liothyronine issued by the South Regional Medicines Optimisation Committee in July is followed by all Clinical Commissioning Groups. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL455 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-04more like thismore than 2019-11-04
answer text <p>It is not the responsibility of the Department to direct clinical commissioning groups (CCGs) on which medicines they can or cannot prescribe. These decisions need to be taken by each individual CCG. However, we would expect CCGs to have regard to the South Regional Medicines Optimisation Committee prescribing guidance.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-04T14:51:03.923Zmore like thismore than 2019-11-04T14:51:03.923Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156576
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liothyronine more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what action they propose to take in relation to thyroid patients who, having previously had successful treatment on dosages of 20mcg and above of liothyronine, are now facing a restriction on the dosage. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL456 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-04more like thismore than 2019-11-04
answer text <p>Whilst NHS England and NHS Improvement will regularly review its guidance, at present, there are no plans to revisit the specific recommendations for liothyronine unless new clinical evidence comes to light. Decisions on appropriate treatment for thyroid patients and doses are taken in accordance with a clinical management plan and implemented by the clinician.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-04T14:53:13.107Zmore like thismore than 2019-11-04T14:53:13.107Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156577
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liothyronine: Merseyside more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what further proof of eligibility for treatment with liothyronine is required for those patients, in Clinical Commissioning Groups (CCG) who are members of the Pan Mersey Area Prescribing Committee, for whom an endocrinologist has confirmed levothyroxine treatment has not been suitable and has recommended they are prescribed liothyronine, and where the CCG is requiring an Individual Funding Request process be undergone before treatment can be permitted. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL457 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-04more like thismore than 2019-11-04
answer text <p>In the absence of positive National Institute for Health and Care Excellence technology appraisal guidance, any funding decisions should be made by National Health Service commissioners (including NHS England and NHS Improvement in respect of specialised services), based on an assessment of the available evidence and on the basis of an individual patient’s clinical circumstances. The NHS Constitution states that patients have the right to expect local decisions on the funding of drugs and treatments “to be made rationally following a proper consideration of the evidence”. If an NHS commissioner decides not to fund a drug, then it should explain that decision.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-04T14:52:02.657Zmore like thismore than 2019-11-04T14:52:02.657Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156578
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments: Finance more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether Individual Funding Requests are intended to be used for rationing access to NHS treatments, such as liothyronine, where there is a recognised cohort of patients. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL458 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>Individual Funding Requests are not intended to be used for rationing treatments, such as liothyronine. All clinical commissioning groups have their own Individual Funding Request policies that enable commissioners to focus on commissioning services that will meet the majority of their local population’s needs without spending funds on services that very few people may need access to.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T13:08:33.137Zmore like thismore than 2019-11-05T13:08:33.137Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156579
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liothyronine more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how many Individual Funding Requests have been received for treatment with liothyronine since the start of the Low Priority Prescribing Project Programme in 2017. more like this
tabling member printed
Lord Hunt of Kings Heath more like this
uin HL459 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>NHS England has advised that treatment with liothyronine is commissioned by clinical commissioning groups and that it does not collate information on Individual Funding Requests centrally.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T13:08:19.223Zmore like thismore than 2019-11-05T13:08:19.223Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
2024
label Biography information for Lord Hunt of Kings Heath more like this
1156590
registered interest false more like this
date remove maximum value filtermore like thismore than 2019-10-28
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Mental Health Services: Staff more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what accountability mechanisms are in place to ensure local NHS People Plans include a mental health workforce strategy to reduce vacancy rates, retain staff and create the new roles needed to fulfil their proposals on mental health. more like this
tabling member printed
Baroness Parminter more like this
uin HL470 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-11-05more like thismore than 2019-11-05
answer text <p>Supporting and expanding the mental health workforce is a key priority for this Government. The interim NHS People Plan set out the immediate actions we will take to fill vacancies and secure the staff we need for the future.</p><p>The full NHS People Plan will set out a new operating model for workforce and systematic actions to ensure healthy, inclusive and compassionate cultures for all staff working in the National Health Service, both improving staff experience and enhancing retention.</p><p>Alongside this, NHS England and NHS Improvement will work closely with all local sustainability and transformation partnerships and integrated care systems to refine and improve their existing mental health workforce plans and develop robust plans to deliver the NHS Long Term Plan ambitions.</p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
question first answered
less than 2019-11-05T17:26:31.093Zmore like thismore than 2019-11-05T17:26:31.093Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
4178
label Biography information for Baroness Parminter more like this